KR20180085049A - 아리피프라졸을 유효 성분으로 포함하는 케이크 형상 조성물이 함유된 의료용 기구 및 아리피프라졸을 유효 성분으로 포함하는 케이크 형상 조성물 - Google Patents

아리피프라졸을 유효 성분으로 포함하는 케이크 형상 조성물이 함유된 의료용 기구 및 아리피프라졸을 유효 성분으로 포함하는 케이크 형상 조성물 Download PDF

Info

Publication number
KR20180085049A
KR20180085049A KR1020187020066A KR20187020066A KR20180085049A KR 20180085049 A KR20180085049 A KR 20180085049A KR 1020187020066 A KR1020187020066 A KR 1020187020066A KR 20187020066 A KR20187020066 A KR 20187020066A KR 20180085049 A KR20180085049 A KR 20180085049A
Authority
KR
South Korea
Prior art keywords
aripiprazole
active ingredient
cake composition
medical device
device containing
Prior art date
Application number
KR1020187020066A
Other languages
English (en)
Other versions
KR101962085B1 (ko
Inventor
쇼고 히라오카
기요시 다니구치
Original Assignee
오츠카 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45592780&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20180085049(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 오츠카 세이야쿠 가부시키가이샤 filed Critical 오츠카 세이야쿠 가부시키가이샤
Publication of KR20180085049A publication Critical patent/KR20180085049A/ko
Application granted granted Critical
Publication of KR101962085B1 publication Critical patent/KR101962085B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/284—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle comprising means for injection of two or more media, e.g. by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
    • F04C2270/00—Control; Monitoring or safety arrangements
    • F04C2270/04—Force
    • F04C2270/042—Force radial
    • F04C2270/0421—Controlled or regulated

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Mechanical Engineering (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Dispersion Chemistry (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020187020066A 2011-01-24 2012-01-17 아리피프라졸을 유효 성분으로 포함하는 케이크 형상 조성물 KR101962085B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011011711 2011-01-24
JPJP-P-2011-011711 2011-01-24
PCT/JP2012/051285 WO2012102216A1 (en) 2011-01-24 2012-01-17 Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020137022304A Division KR101905215B1 (ko) 2011-01-24 2012-01-17 아리피프라졸을 유효 성분으로 포함하는 케이크 형상 조성물이 함유된 의료용 기구 및 아리피프라졸을 유효 성분으로 포함하는 케이크 형상 조성물

Publications (2)

Publication Number Publication Date
KR20180085049A true KR20180085049A (ko) 2018-07-25
KR101962085B1 KR101962085B1 (ko) 2019-03-25

Family

ID=45592780

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020137022304A KR101905215B1 (ko) 2011-01-24 2012-01-17 아리피프라졸을 유효 성분으로 포함하는 케이크 형상 조성물이 함유된 의료용 기구 및 아리피프라졸을 유효 성분으로 포함하는 케이크 형상 조성물
KR1020187020066A KR101962085B1 (ko) 2011-01-24 2012-01-17 아리피프라졸을 유효 성분으로 포함하는 케이크 형상 조성물

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020137022304A KR101905215B1 (ko) 2011-01-24 2012-01-17 아리피프라졸을 유효 성분으로 포함하는 케이크 형상 조성물이 함유된 의료용 기구 및 아리피프라졸을 유효 성분으로 포함하는 케이크 형상 조성물

Country Status (29)

Country Link
US (2) US11648347B2 (ko)
EP (1) EP2667856B9 (ko)
JP (2) JP5980215B2 (ko)
KR (2) KR101905215B1 (ko)
CN (2) CN105125509B (ko)
AR (2) AR084914A1 (ko)
AU (1) AU2012209853B2 (ko)
BR (1) BR112013018664B1 (ko)
CA (2) CA2824982C (ko)
CO (1) CO6751272A2 (ko)
CY (1) CY1124447T1 (ko)
DK (1) DK2667856T3 (ko)
EA (1) EA024814B1 (ko)
ES (1) ES2884825T3 (ko)
HR (1) HRP20211295T1 (ko)
HU (1) HUE055836T2 (ko)
IL (1) IL227364A (ko)
JO (1) JO3508B1 (ko)
LT (1) LT2667856T (ko)
MX (1) MX354319B (ko)
MY (1) MY163272A (ko)
PL (1) PL2667856T3 (ko)
PT (1) PT2667856T (ko)
SG (2) SG191892A1 (ko)
SI (1) SI2667856T1 (ko)
TW (1) TWI594753B (ko)
UA (1) UA113727C2 (ko)
WO (1) WO2012102216A1 (ko)
ZA (1) ZA201305199B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020017826A1 (ko) 2018-07-20 2020-01-23 주식회사 엘지화학 파우치형 이차전지의 제조방법

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20200109A1 (ar) 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن
EP3009354A1 (en) * 2014-10-15 2016-04-20 F. Hoffmann-La Roche AG Method for providing in a primary packaging container a dried solid product containing an active pharmaceutical ingredient
EP3569216A1 (en) 2015-06-19 2019-11-20 Baxalta Incorporated Pooling device for single or multiple medical containers
ITUA20164317A1 (it) * 2016-06-13 2017-12-13 Orofino Pharmaceuticals Group Srl Dispositivo di iniezione pre-riempito a tripla camera
SG11202004467PA (en) * 2017-11-17 2020-06-29 Swedish Orphan Biovitrum Ab Publ Syringe assembly with ion-exchange material
US11903900B2 (en) 2018-10-03 2024-02-20 Takeda Pharmaceutical Company Limited Packaging for multiple containers
CN114786724A (zh) 2019-12-16 2022-07-22 尼普洛株式会社 防聚集剂以及使用该防聚集剂的药物组合物和医疗用设备
AU2021235750A1 (en) * 2020-03-09 2022-09-22 Idexx Laboratories, Inc. Method for removing interfering components of a liquid sample prior to dispensing same on a chemical reagent test slide
GR1010624B (el) * 2023-03-23 2024-01-30 Φαρματεν Α.Β.Ε.Ε., Φαρμακευτικο σκευασμα που περιλαμβανει αριπιπραζολη και μεθοδος για την παρασκευη αυτου

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JPH08112333A (ja) 1994-10-12 1996-05-07 Maeda Sangyo Kk 用時溶解型プレフィルドシリンジの凍結乾燥製剤充填方法
KR20060118450A (ko) * 2003-10-23 2006-11-23 오츠카 세이야쿠 가부시키가이샤 방출 조절된 멸균 아리피프라졸 주사제, 그 제조방법 및그를 이용한 치료방법
KR20070090070A (ko) * 2003-10-23 2007-09-05 브리스톨-마이어스 스큅 컴퍼니 목적하는 평균 입자크기의 멸균 아리피프라졸을 제조하는방법
KR20100057020A (ko) * 2007-07-31 2010-05-28 오쓰까 세이야꾸 가부시키가이샤 아리피프라졸 현탁액 및 냉동건조 제형의 제조 방법

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58165852A (ja) * 1982-03-26 1983-09-30 小太郎漢方製薬株式会社 薬品、食品等の濃縮液を乾燥する方法及びその装置
JPH02225370A (ja) * 1989-02-27 1990-09-07 Mitsubishi Electric Corp マイカ複合セラミックスの製法
JPH0626570B2 (ja) * 1991-01-31 1994-04-13 参天製薬株式会社 二層式注射器の注射筒
US5290228A (en) * 1990-11-17 1994-03-01 Santen Seiyaku Kabushiki Kaisha Two-compartment syringe
JP3121632B2 (ja) 1991-04-30 2001-01-09 株式会社アズウェル 凍結乾燥製剤の製造方法及び凍結真空乾燥装置
JP2767016B2 (ja) * 1992-07-14 1998-06-18 株式会社大塚製薬工場 凍結乾燥用容器
AR247101A1 (es) 1993-03-10 1994-11-30 Moreno Saul Szapiro Jaime Luis Jeringa descartable de doble camara para la dilucion y administracion simultanea de drogas en polvo
DE4445969C1 (de) 1994-12-22 1996-03-14 Schott Glaswerke Spritzenzylinder für eine Zweikammer-Fertigspritze, Zweikammer-Fertigspritze und Verfahren zum Herstellen und Füllen derselben
US5876372A (en) 1995-03-22 1999-03-02 Abbott Laboratories Syringe system accomodating seperate prefilled barrels for two constituents
US5607400A (en) 1995-05-19 1997-03-04 Becton, Dickinson And Company Pre-fillable syringe and stopper assembly therefor
JP3654685B2 (ja) * 1995-05-26 2005-06-02 株式会社ミューチュアル 薬液の凍結乾燥方法及び凍結乾燥薬剤の充填包装方法
US5971953A (en) 1998-01-09 1999-10-26 Bachynsky; Nicholas Dual chamber syringe apparatus
JPH11155951A (ja) 1997-12-01 1999-06-15 Kaken Pharmaceut Co Ltd 減圧シリンジおよびその製造方法
US6200627B1 (en) 1998-03-17 2001-03-13 Becton, Dickinson And Company Low silicone glass prefillable syringe
US6093175A (en) 1998-06-05 2000-07-25 Becton Dickinson And Company Localized lubrication of syringe barrels and stoppers
US6149628A (en) 1998-07-20 2000-11-21 Szapiro; Jaime Luis Syringe with two variable volume chambers for containing and administering mixtures of products provided separately
DE60023677T2 (de) * 1999-04-16 2006-08-24 Becton Dickinson And Co. Stiftförmiger injektor mit merkmalen zur automatischen substanzkombination
FR2799654B1 (fr) * 1999-10-13 2002-01-11 Sod Conseils Rech Applic Dispositif pour reconstituer une solution, une suspension ou une dispersion therapeutique et procede de preparation et de conditionnement dans ce dispositif
US7621887B2 (en) 2000-10-10 2009-11-24 Meridian Medical Technologies, Inc. Wet/dry automatic injector assembly
US7021561B2 (en) * 2001-12-18 2006-04-04 Becton, Dickinson And Company Spray device and method
WO2004064901A2 (en) 2003-01-20 2004-08-05 Jarto Holding Aps Syringe to be pre-filled and for long-term storage of medicament
TW200526268A (en) 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition
JP2005200409A (ja) 2003-12-17 2005-07-28 Takeda Chem Ind Ltd 注射剤
JP2005306216A (ja) 2004-04-21 2005-11-04 Nsk Ltd 車両用ステアリングシステム
EP1933814A2 (en) * 2005-09-15 2008-06-25 Elan Pharma International Limited Nanoparticulate aripiprazole formulations
JP4373983B2 (ja) 2006-01-27 2009-11-25 三菱電機インフォメーションシステムズ株式会社 流通経路管理装置及び流通経路管理プログラム
DE102008030268B3 (de) 2008-06-19 2010-02-04 Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg Verfahren zum Befüllen von Doppelkammersystemen in vorsterilisierbaren Trägersystemen und vorsterilisierbares Trägersystem
JP2010025370A (ja) 2008-07-15 2010-02-04 Hosokawa Yoko Co Ltd 凍結乾燥容器および凍結乾燥物の製造方法
JP4536825B1 (ja) 2010-02-05 2010-09-01 株式会社アルテ 二室式容器兼用注射器の製造方法及び製剤入りスリーブ

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JPH08112333A (ja) 1994-10-12 1996-05-07 Maeda Sangyo Kk 用時溶解型プレフィルドシリンジの凍結乾燥製剤充填方法
KR20060118450A (ko) * 2003-10-23 2006-11-23 오츠카 세이야쿠 가부시키가이샤 방출 조절된 멸균 아리피프라졸 주사제, 그 제조방법 및그를 이용한 치료방법
JP2007509148A (ja) 2003-10-23 2007-04-12 大塚製薬株式会社 放出制御性無菌注射アリピプラゾール製剤および方法
KR20070090070A (ko) * 2003-10-23 2007-09-05 브리스톨-마이어스 스큅 컴퍼니 목적하는 평균 입자크기의 멸균 아리피프라졸을 제조하는방법
KR20100057020A (ko) * 2007-07-31 2010-05-28 오쓰까 세이야꾸 가부시키가이샤 아리피프라졸 현탁액 및 냉동건조 제형의 제조 방법

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020017826A1 (ko) 2018-07-20 2020-01-23 주식회사 엘지화학 파우치형 이차전지의 제조방법

Also Published As

Publication number Publication date
AU2012209853A1 (en) 2013-07-25
CY1124447T1 (el) 2022-07-22
EA024814B1 (ru) 2016-10-31
CN105125509B (zh) 2019-01-11
MX2013008433A (es) 2013-08-12
PL2667856T3 (pl) 2021-11-29
SG10201600202UA (en) 2016-02-26
DK2667856T3 (da) 2021-08-30
CN103327968A (zh) 2013-09-25
JO3508B1 (ar) 2020-07-05
CO6751272A2 (es) 2013-09-16
KR101962085B1 (ko) 2019-03-25
AR122575A2 (es) 2022-09-21
JP6289541B2 (ja) 2018-03-07
CA2910333A1 (en) 2012-08-02
US20130302384A1 (en) 2013-11-14
JP2014504511A (ja) 2014-02-24
IL227364A (en) 2017-07-31
EP2667856A1 (en) 2013-12-04
UA113727C2 (xx) 2017-03-10
SG191892A1 (en) 2013-08-30
BR112013018664B1 (pt) 2021-06-01
NZ613064A (en) 2015-10-30
TW201309294A (zh) 2013-03-01
AR084914A1 (es) 2013-07-10
AU2012209853B2 (en) 2016-06-16
EP2667856B9 (en) 2021-12-01
MY163272A (en) 2017-08-30
JP5980215B2 (ja) 2016-08-31
ES2884825T3 (es) 2021-12-13
KR20140114270A (ko) 2014-09-26
EP2667856B1 (en) 2021-07-28
JP2016155872A (ja) 2016-09-01
CN103327968B (zh) 2016-09-07
CA2910333C (en) 2017-03-07
CN105125509A (zh) 2015-12-09
KR101905215B1 (ko) 2018-10-05
HRP20211295T1 (hr) 2021-11-12
LT2667856T (lt) 2021-11-25
MX354319B (es) 2018-02-26
IL227364A0 (en) 2013-09-30
TWI594753B (zh) 2017-08-11
US20230381416A1 (en) 2023-11-30
BR112013018664A2 (pt) 2016-10-18
CA2824982A1 (en) 2012-08-02
SI2667856T1 (sl) 2021-09-30
ES2884825T9 (es) 2022-01-25
ZA201305199B (en) 2014-09-25
US11648347B2 (en) 2023-05-16
PT2667856T (pt) 2021-09-02
HUE055836T2 (hu) 2021-12-28
WO2012102216A1 (en) 2012-08-02
CA2824982C (en) 2016-08-09
EA201391078A1 (ru) 2014-01-30

Similar Documents

Publication Publication Date Title
KR20180085049A (ko) 아리피프라졸을 유효 성분으로 포함하는 케이크 형상 조성물이 함유된 의료용 기구 및 아리피프라졸을 유효 성분으로 포함하는 케이크 형상 조성물
EP3216448B8 (en) Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
EP2522653A4 (en) BIGUANIDE DERIVATIVE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE BIGUANIDE DERIVATIVE AS AN ACTIVE SUBSTANCE
HK1201770A1 (en) Antiseptic cap equipped syringe
EP2575937B8 (en) Medicament delivery device
EP2555819A4 (en) Medicament delivery device
EP2891097A4 (en) Patient specific implant technology
AU2013345540A8 (en) Growth device for crop, use of such a device, and a series of growth devices
EP2588172A4 (en) Medicament delivery device
EP2563431A4 (en) Medicament delivery device
EP2566538A4 (en) Medicament delivery device
EP2640447A4 (en) Medicament delivery device
GB2505860B (en) Aripiprazole medicament formulation and preparation method therefor
EP2543354A4 (en) Medical device
EP2611481A4 (en) Medicament delivery device
EP2623038A4 (en) Medical device
EP2628505A4 (en) Medical device
EP2924042A4 (en) BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP2636666A4 (en) TRANS-2 DECENTRIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THEREOF
HK1179534A1 (en) Coated preparation containing azosemide as active ingredient
EP2871187A4 (en) NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
EP2864328B8 (en) Pharmaceutically active compounds
EP2476420B8 (en) Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same
AU2012265231A1 (en) Nasal pharmaceutical formulation
EP2704570A4 (en) ACTIVE SUBSTANCES, PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant